1Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
2Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA
3Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, Arizona, USA
4Division of Digestive Diseases and Transplantation and Immunology, Departments of Medicine and Surgery, Yale University, New Haven, Connecticut, USA
5Department of Medicine, Division of Digestive and Liver Diseases, UT Southwestern Medical Center at Dallas, Dallas, Texas, USA
6Department of Medicine, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
Correspondence: Luke Hillman, MD, Department of Medicine, Northwestern University Feinberg School of Medicine, 251 E Huron Street, Galter Suite 3-150, Chicago, Illinois, USA. E-mail: [email protected]
SUPPLEMENTARY MATERIAL accompanies this paper at https://links.lww.com/AJG/A640
Received 01 January 2016; accepted 02 February 2016
Guarantors of the article: Luke Hillman, MD and Daniel Ganger, MD.
Specific author contributions: Statistical analysis: Luke Hillman, Michelle Gottfried, and Daniel Ganger. All authors participated in data acquisition, analysis or interpretation of data. All authors were responsible for drafting, critical revision, and approval of the final manuscript.
Financial support: The Acute Liver Failure Study Group is funded principally by the National Institutes of Health, under grant U01 DK058369.
Potential competing interests: William M. Lee provides consulting services to Novartis, Sanofi and Lilly and receives research support from BMS, Gilead and Merck. The remaining authors declare no conflict of interest.
